TY - JOUR AU - Zhou, Xuanfang AU - Meng, Zhouqi AU - She, Jialin AU - Zhang, Yaojia AU - Yi, Xuan AU - Zhou, Hailin AU - Zhong, Jing AU - Dong, Ziliang AU - Han, Xiao AU - Chen, Muchao AU - Fan, Qin AU - Yang, Kai AU - Wang, Chao PY - 2020/04/24 Y2 - 2024/03/28 TI - Near-Infrared Light-Responsive Nitric Oxide Delivery Platform for Enhanced Radioimmunotherapy JF - Nano-Micro Letters JA - Nano-Micro Lett VL - 12 IS - SE - Articles DO - 10.1007/s40820-020-00431-3 UR - https://nmlett.org/index.php/nml/article/view/457 SP - 100 AB - <p>Radiotherapy (RT) is a widely used way for cancer treatment. However, the efficiency of RT may come with various challenges such as low specificity, limitation by resistance, high dose and so on. Nitric oxide (NO) is known a very effective radiosensitizer of hypoxic tumor. However, NO cannot circulate in body with high concentration. Herein, an NIR light-responsive NO delivery system is developed for controlled and precisely release of NO to hypoxic tumors during radiotherapy. <em>Tert</em>-Butyl nitrite, which is an efficient NO source, is coupled to Ag<sub>2</sub>S quantum dots (QDs). NO could be generated and released from the Ag<sub>2</sub>S QDs effectively under the NIR irradiation due to the thermal effect. In addition, Ag is also a type of heavy metal that can benefit the RT therapy. We demonstrate that Ag<sub>2</sub>S NO delivery platforms remarkably maximize radiotherapy effects to inhibit tumor growth in CT26 tumor model. Furthermore, immunosuppressive tumor microenvironment is improved by our NO delivery system, significantly enhancing the anti-PD-L1 immune checkpoint blockade therapy. 100% survival rate is achieved by the radio-immune combined therapy strategy based on the Ag<sub>2</sub>S NO delivery platforms. Our results suggest the promise of Ag<sub>2</sub>S NO delivery platforms for multifunctional cancer radioimmunotherapy.</p><p>Highlights:</p><p>1 Ag<sub>2</sub>S NO delivery platforms maximize radiotherapy effects remarkably to inhibit the tumor growth.<br>2 Immunosuppressive tumor microenvironment was improved by Ag<sub>2</sub>S NO delivery system, significantly enhancing the anti-PD-L1 immune checkpoint blockade therapy.</p> ER -